info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Pediatric Medicine Market Research Report Information by Type (Respiratory Drugs, Digestive Medicine, Anti-Infective Drugs, Nutritional Supplements and Others), By Application (Hospital, Pharmacy and Clinic), By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/HC/17647-HCR | 128 Pages | Author: Rahul Gotadki| December 2024

Market Segmentation


Pediatric Medicine Type Outlook (USD Billion, 2018-2032)




  • Respiratory Drugs




  • Digestive Medicine




  • Anti-Infective Drugs




  • Nutritional Supplements




  • Others




Pediatric Medicine Application Outlook (USD Billion, 2018-2032)




  • Hospitals




  • Pharmacy




  • Clinic




Pediatric Medicine Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • North America Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • North America Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • US Outlook (USD Billion, 2018-2032)




    • US Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • US Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • CANADA Outlook (USD Billion, 2018-2032)




    • CANADA Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • CANADA Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic








  • Europe Outlook (USD Billion, 2018-2032)




    • Europe Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • Europe Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • Germany Outlook (USD Billion, 2018-2032)




    • Germany Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • Germany Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • France Outlook (USD Billion, 2018-2032)




    • France Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • France Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • UK Outlook (USD Billion, 2018-2032)




    • UK Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • UK Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • ITALY Outlook (USD Billion, 2018-2032)




    • ITALY Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • ITALY Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • SPAIN Outlook (USD Billion, 2018-2032)




    • Spain Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • Spain Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • REST OF EUROPE Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • Asia-Pacific Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • China Outlook (USD Billion, 2018-2032)




    • China Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • China Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • Japan Outlook (USD Billion, 2018-2032)




    • Japan Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • Japan Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • India Outlook (USD Billion, 2018-2032)




    • India Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • India Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • Australia Outlook (USD Billion, 2018-2032)




    • Australia Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • Australia Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • Rest of Asia-Pacific Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • Rest of the World Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • Middle East Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • Africa Outlook (USD Billion, 2018-2032)




    • Africa Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • Africa Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic






    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America Pediatric Medicine by Type




      • Respiratory Drugs




      • Digestive Medicine




      • Anti-Infective Drugs




      • Nutritional Supplements




      • Others






    • Latin America Pediatric Medicine by Application




      • Hospitals




      • Pharmacy




      • Clinic







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3.Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2.Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL PEDIATRIC MEDICINE MARKET, BY TYPE

6.1. Overview

6.2. Respiratory Drugs

6.3. Digestive Medicine

6.4. Anti-Infective Drugs

6.5. Nutritional Supplements

6.6. Others

7. GLOBAL PEDIATRIC MEDICINE MARKET, BY APPLICATION

7.1. Overview

7.2. Hospital

7.3. Pharmacy

7.4. Clinic

8. GLOBAL PEDIATRIC MEDICINE MARKET, BY REGION

8.1. Overview

8.1. North America

8.1.1. US

8.1.2. Canada

8.2. Europe

8.2.1. Germany

8.2.2. France

8.2.3. UK

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Europe

8.3. Asia-Pacific

8.3.1. China

8.3.2. India

8.3.3. Japan

8.3.4. South Korea

8.3.5. Australia

8.3.6. Rest of Asia-Pacific

8.4. Rest of the World

8.4.1. Middle East

8.4.2. Africa

8.4.3. Latin America

9. COMPETITIVE LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Pediatric Medicine Market,

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Pediatric Medicine Market,

9.7. Key developments and Growth Strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger & Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2022

9.8.2. Major Players R&D Expenditure. 2022

10. COMPANY PROFILES

10.1. Pfizer

10.1.1. Company Overview

10.1.2. Financial Overview

10.1.3. Products Offered

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Novartis

10.2.1. Company Overview

10.2.2. Financial Overview

10.2.3. Products Offered

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. GlaxoSmithKline

10.3.1. Company Overview

10.3.2. Financial Overview

10.3.3. Products Offered

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. JOHNSON & JOHNSON

10.4.1. Company Overview

10.4.2. Financial Overview

10.4.3. Products Offered

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. Sanofi

10.5.1. Company Overview

10.5.2. Financial Overview

10.5.3. Products Offered

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. AstraZeneca

10.6.1. Company Overview

10.6.2. Financial Overview

10.6.3. Products Offered

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Merck & Co.

10.7.1. Company Overview

10.7.2. Financial Overview

10.7.3. Products Offered

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Roche

10.8.1. Company Overview

10.8.2. Financial Overview

10.8.3. Products Offered

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Eli Lilly and Company

10.9.1. Company Overview

10.9.2. Financial Overview

10.9.3. Products Offered

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Abbott Laboratories

10.10.1. Company Overview

10.10.2. Financial Overview

10.10.3. Products Offered

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL PEDIATRIC MEDICINE MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL PEDIATRIC MEDICINE MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 5 NORTH AMERICA: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 7 US: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 8 US: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 9 CANADA: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 10 CANADA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 1 EUROPE: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 2 EUROPE: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 3 GERMANY: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 4 GERMANY: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 5 FRANCE: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 6 FRANCE: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 7 ITALY: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 8 ITALY: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 9 SPAIN: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 10 SPAIN: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 11 UK: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 12 UK: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 13 REST OF EUROPE: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 14 REST OF EUROPE: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 15 ASIA-PACIFIC: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 16 ASIA-PACIFIC: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 17 JAPAN: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 18 JAPAN: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 19 JAPAN: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 20 CHINA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 21 INDIA: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 22 INDIA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 23 AUSTRALIA: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 24 AUSTRALIA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 25 SOUTH KOREA: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 26 SOUTH KOREA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 27 REST OF ASIA-PACIFIC: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 28 REST OF ASIA-PACIFIC: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 29 REST OF THE WORLD: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 30 REST OF THE WORLD: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 31 MIDDLE EAST: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 32 MIDDLE EAST: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 33 AFRICA: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 34 AFRICA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 35 LATIN AMERICA: PEDIATRIC MEDICINE MARKET, BY TYPE, 2018-2032 (USD BILLION)

TABLE 36 LATIN AMERICA: PEDIATRIC MEDICINE MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PEDIATRIC MEDICINE MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PEDIATRIC MEDICINE MARKET

FIGURE 4 GLOBAL PEDIATRIC MEDICINE MARKET, SHARE (%), BY TYPE, 2022

FIGURE 5 GLOBAL PEDIATRIC MEDICINE MARKET, SHARE (%), BY APPLICATION, 2022

FIGURE 6 GLOBAL PEDIATRIC MEDICINE MARKET, SHARE (%), BY REGION, 2022

FIGURE 7 NORTH AMERICA: PEDIATRIC MEDICINE MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 EUROPE: PEDIATRIC MEDICINE MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 ASIA-PACIFIC: PEDIATRIC MEDICINE MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 REST OF THE WORLD: PEDIATRIC MEDICINE MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 GLOBAL PEDIATRIC MEDICINE MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 12 PFIZER: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 13 PFIZER: SWOT ANALYSIS

FIGURE 14 NOVARTIS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 NOVARTIS: SWOT ANALYSIS

FIGURE 16 GLAXOSMITHKLINE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 GLAXOSMITHKLINE: SWOT ANALYSIS

FIGURE 18 JOHNSON & JOHNSON: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 JOHNSON & JOHNSON: SWOT ANALYSIS

FIGURE 20 SANOFI: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 SANOFI: SWOT ANALYSIS

FIGURE 22 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 ASTRAZENECA: SWOT ANALYSIS

FIGURE 24 MERCK & CO.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 MERCK & CO.: SWOT ANALYSIS

FIGURE 26 ROCHE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 ROCHE: SWOT ANALYSIS

FIGURE 28 ELI LILLY AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 ELI LILLY AND COMPANY: SWOT ANALYSIS

FIGURE 30 ABBOTT LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 ABBOTT LABORATORIES: SWOT ANALYSIS

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.